Drug interactions
Carbimazole + Rosuvastatin
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Overview
Carbimazole can induce or worsen hypothyroidism; hypothyroidism is a recognized risk factor for rosuvastatin-associated myopathy/rhabdomyolysis, increasing the likelihood of muscle toxicity during periods of low thyroid function.
Mechanism of action
Pharmacodynamic: Hypothyroidism predisposes to statin-induced myotoxicity; no direct CYP/transporter interaction is expected.
Clinical management
Ensure the patient is euthyroid before initiating or up-titrating rosuvastatin; monitor TSH every 4–6 weeks after carbimazole dose changes; counsel patients to report muscle pain/weakness or dark urine; if hypothyroidism develops or muscle symptoms occur, check CK and consider holding or reducing rosuvastatin until euthyroid status is restored.
Drug reference
References
- CRESTOR (rosuvastatin calcium) Prescribing Information – Warnings and Precautions: Skeletal Muscle Effects (risk increased in patients with hypothyroidism) — FDA Label
- Statin muscle symptoms: Evaluation and management — UpToDate
- Methimazole (systemic) – Drug monograph (risk of hypothyroidism; monitoring recommendations) — Lexicomp
Frequently asked questions
Can I take Carbimazole with Rosuvastatin?
The interaction is rated: Moderate. Carbimazole can induce or worsen hypothyroidism; hypothyroidism is a recognized risk factor for rosuvastatin-associated myopathy/rhabdomyolysis, increasing the likelihood of muscle toxicity during periods of low thyroid function.
How serious is the interaction between Carbimazole and Rosuvastatin?
The interaction is rated: Moderate. Evidence level: Moderate.
How is the interaction between Carbimazole and Rosuvastatin managed?
Ensure the patient is euthyroid before initiating or up-titrating rosuvastatin; monitor TSH every 4–6 weeks after carbimazole dose changes; counsel patients to report muscle pain/weakness or dark urine; if hypothyroidism develops or muscle symptoms occur, check CK and consider holding or reducing rosuvastatin until euthyroid status is restored.
Why do Carbimazole and Rosuvastatin interact?
Pharmacodynamic: Hypothyroidism predisposes to statin-induced myotoxicity; no direct CYP/transporter interaction is expected.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.